A comparison of the ADAS-cog and computerized cognitive testing (CNTB): Cognitive domains, rater errors, sample size estimates and power
- Published in:
- 2010
- By:
- Publication type:
- Abstract
Works in Alzheimer
Results: 1918
1
2
Aryl acylamidase activity associated with low molecular forms of acetylcholinesterase in the onset of Alzheimer's disease
- Published in:
- 2010
- By:
- Publication type:
- Abstract
3
Chronic administration of CHF5074, a novel gamma-secretase modulator, dose-dependently restores object recognition memory in aged Alzheimer's disease transgenic mice
- Published in:
- 2010
- By:
- Publication type:
- Abstract
4
Perlecan domain V inhibits alpha 2 integrin mediated Abeta neurotoxicity
- Published in:
- 2010
- By:
- Publication type:
- Abstract
5
Development of Klotho enhancers as novel therapeutics for Alzheimer's disease
- Published in:
- 2010
- By:
- Publication type:
- Abstract
6
Exploiting prime-boost regimen and various delivery strategies to improve Alzhaimer's disease DNA vaccine efficacy
- Published in:
- 2010
- By:
- Publication type:
- Abstract
7
Central and peripheral pharmacodynamic effects of BACE1 inhibition following oral administration of LY2811376 to PDAPP mice and beagle dog
- Published in:
- 2010
- By:
- Publication type:
- Abstract
8
Simvastatin facilitates Abeta immunotherapy in mice
- Published in:
- 2010
- By:
- Publication type:
- Abstract
9
Oral treatment with the amyloid-beta oligomer precipitating substance D3 improves pathology of Alzheimer's transgenic mice
- Published in:
- 2010
- By:
- Publication type:
- Abstract
10
Medication use differs in frontotemporal dementia and Alzheimer's disease
- Published in:
- 2010
- By:
- Publication type:
- Abstract
11
Development of conformational monoclonal antibodies that detects multiple amyloid proteins
- Published in:
- 2010
- By:
- Publication type:
- Abstract
12
Swarna bhasma (gold ash): Treatment / prevention of Alzheimer's disease
- Published in:
- 2010
- By:
- Publication type:
- Abstract
13
Anti-PrP<sup>C</sup> monoclonal antibody infusion as a novel treatment for Aß oligomer cognitive deficits
- Published in:
- 2010
- By:
- Publication type:
- Abstract
14
Results from the argentinean cerebrolysin registry (ACeR): Clinical efficacy
- Published in:
- 2010
- By:
- Publication type:
- Abstract
15
Latrepirdine (Dimebon™) modulate mitochondrial dynamics in AD cell models
- Published in:
- 2010
- By:
- Publication type:
- Abstract
16
Patient specific prescriber education and feedback is effective in reducing use of antipsychotics in the elderly
- Published in:
- 2010
- By:
- Publication type:
- Abstract
17
Cholinesterase inhibitors and memantine use by patients in the Alzheimer's disease neuroimaging initiative
- Published in:
- 2010
- By:
- Publication type:
- Abstract
18
Galantamine versus nootropic medication in the treatment of Alzheimer's disease: An observational trial under naturalistic conditions
- Published in:
- 2010
- By:
- Publication type:
- Abstract
19
A randomized, placebo-controlled trial of intranasal insulin in amnestic MCI and early Alzheimer's
- Published in:
- 2010
- By:
- Publication type:
- Abstract
20
Attentional deficits in the dementias: Behavioural and treatment implications
- Published in:
- 2010
- By:
- Publication type:
- Abstract
21
Rationale and strategy for thalidomide as a BACE 1 inhibitor for a phase II randomized clinical trial in mild-to-moderate Alzheimer's disease
- Published in:
- 2010
- By:
- Publication type:
- Abstract
22
Bayesian cognitive models increase sensitivity for detecting treatment effect: Analysis of Flurizan phase III trial data
- Published in:
- 2010
- By:
- Publication type:
- Abstract
23
Enhancing global reliability of the ADAS-cog and MMSE: part 1-the harmonization/standardization project of word lists and phrases
- Published in:
- 2010
- By:
- Publication type:
- Abstract
24
Safety and pharmacokinetics following a single 10-minute intravenous infusion of the anti-amyloid mAb ponezumab (PF-04360365) in patients with mild to moderate Alzheimer's disease
- Published in:
- 2010
- By:
- Publication type:
- Abstract
25
Phosphatidylserine containing Omega-3 fatty acids may improve memory abilities in nondemented elderly with memory complaints: A double-blind placebo-controlled trial
- Published in:
- 2010
- By:
- Publication type:
- Abstract
26
Neurotrophic and cholinergic treatment in Alzheimer's disease: Results of a randomized clinical trial
- Published in:
- 2010
- By:
- Publication type:
- Abstract
27
Development of AFFITOPE vaccines for Alzheimer's disease
- Published in:
- 2010
- By:
- Publication type:
- Abstract
28
Effect of list word presentation order on noise level in verbal memory tasks
- Published in:
- 2010
- By:
- Publication type:
- Abstract
29
Fitness for the aging brain study II: A multisite randomized controlled trial to determine the clinical benefits of physical activity for patients with mild-to-moderate Alzheimer's disease
- Published in:
- 2010
- By:
- Publication type:
- Abstract
30
Antioxidant supplementation and the course of dementia in down syndrome
- Published in:
- 2010
- By:
- Publication type:
- Abstract
31
Long-term lithium treatment for patients with mild cognitive impairment: Benefits on cognition and evidence of disease modification
- Published in:
- 2010
- By:
- Publication type:
- Abstract
32
Preclinical and early clinical studies of AVN-101, a novel balanced molecule for the treatment of Alzheimer's disease
- Published in:
- 2010
- By:
- Publication type:
- Abstract
33
Conformationally directed immunomodulation for multiple pathological conformers
- Published in:
- 2010
- By:
- Publication type:
- Abstract
34
Oxidative stress-induced mitochondrial failure and brain hypometabolism underlay the pathophysiology of Alzheimer's disease and offer target for treatment: Astonishing effect of melanin and mitochondrial antioxidants
- Published in:
- 2010
- By:
- Publication type:
- Abstract
35
Donepezil promotes the proliferation of neural stem cells in the dentate gyrus of aged mice
- Published in:
- 2010
- By:
- Publication type:
- Abstract
36
The effect of memantine and rivastigmine on synaptic markers and amyloid processing in cell culture and animal models of Alzheimer's disease
- Published in:
- 2010
- By:
- Publication type:
- Abstract
37
Inhibition of MARCKS phosphorylation improves working memory
- Published in:
- 2010
- By:
- Publication type:
- Abstract
38
Aminoff suffering syndrome and decubitus ulcers in advanced dementia
- Published in:
- 2010
- By:
- Publication type:
- Abstract
39
Modulation of the endosome-to-lysosome sorting pathway exerts neuroprotectivity in cellular and animal models of Parkinson's and Alzheimer's disease
- Published in:
- 2010
- By:
- Publication type:
- Abstract
40
Neuroprotective effect of epigallocatechin-3-gallate against chronic alcohol induced cognitive deficits in rats: Possible role of oxidative stress and cytokine signaling
- Published in:
- 2010
- By:
- Publication type:
- Abstract
41
An inhibitor of kynurenine 3-monooxygenase is neuroprotective in a mouse model of Alzheimer's disease
- Published in:
- 2010
- By:
- Publication type:
- Abstract
42
Effects of tetrahydroxystilbene glucoside on multiple targets of Alzheimer's disease in seven Alzheimer-like animal models
- Published in:
- 2010
- By:
- Publication type:
- Abstract
43
Targeting oxidative stress-induced brain hypometabolism and brain mitochondrial failure as new and effective strategies for the prevention and treatment of cognitive decline in elderly demented/depressed patients and those with Alzheimer's disease: New scents on the trail?
- Published in:
- 2010
- By:
- Publication type:
- Abstract
44
Response to cholinesterase inhibitor medication at first renewal in a Canadian provincial drug coverage initiative: the British Columbia Alzheimer's Drug Therapy Initiative (BC ADTI) experience
- Published in:
- 2010
- By:
- Publication type:
- Abstract
45
Activity-dependent neuroprotective protein (ADNP) is regulated in the brains of mouse models of human tauopathies: Toward davunetide replacement therapy
- Published in:
- 2010
- By:
- Publication type:
- Abstract
46
Passive tau immunotherapy diminishes functional decline and clears tau aggregates in a mouse model of tauopathy
- Published in:
- 2010
- By:
- Publication type:
- Abstract
47
Efficacy of microtubule stabilizing drug treatment on axonal transport integrity in a transgenic mouse model of Alzheimer's disease
- Published in:
- 2010
- By:
- Publication type:
- Abstract
48
Chaperone-mediated modulation of tau aggregation correlates with modifications in tau pathology and synaptic plasticity
- Published in:
- 2010
- By:
- Publication type:
- Abstract
49
Sodium selenate specifically boosts PP2A phosphatase, dephosphorylates tau and reverses memory deficits and prevents neurofibrillary tangle formation in Alzheimer's disease models
- Published in:
- 2010
- By:
- Publication type:
- Abstract
50
Liraglutide, a novel drug to treat type 2 diabetes, prevents the impairment of learning and hippocampal synaptic plasticity in an APP/PS-1 mouse model of Alzheimer's disease
- Published in:
- 2010
- By:
- Publication type:
- Abstract